Are you surprised? The timing is interesting with EOLS date right around the corner. Makes me think they are getting approval. Or if anything its at least a hedge.
RVNC’s post-offering cash should be ~$300M (on a pro forma basis), after accounting for the $30M due from Fosun Pharmaceuticals (#msg-145245703), approximately ~$35M cash burn since 9/30/18, and proceeds of the new offering (assuming exercise of the underwiter’s option).
Market Data 
Markets 
AI
